Shots:
The US FDA has granted Breakthrough Device Designation for its NET Device as an aid in reducing psychostimulant use in adults diagnosed with stimulant use disorder, incl. cocaine use disorder & amphetamine-type/ methamphetamine use disorder
NET Recovery is designing a pivotal randomized controlled trial intended to support FDA marketing authorization, which the company believes…
